IS-10506
- Generic Name
- IS-10506
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis
Phase 1
Not yet recruiting
- Conditions
- ProbioticOcular Surface DiseaseOcular DiseasesOcular DrynessGut Microbiome DysbiosisGut -microbiota
- Interventions
- Drug: Placebo Drug
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Mohsen Pourazizi
- Target Recruit Count
- 32
- Registration Number
- NCT06793514
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
Phase 4
Not yet recruiting
- Conditions
- Gastro-oesophageal Reflux Disease
- Interventions
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 120
- Registration Number
- NCT06664008
Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee
Phase 4
Not yet recruiting
- Conditions
- Prosthetic-joint InfectionDysbiosis
- Interventions
- Other: Standard of care
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Boston Medical Center
- Target Recruit Count
- 152
- Registration Number
- NCT06636669
- Locations
- 🇺🇸
Boston Medical Center, Orthopedic Surgery, Boston, Massachusetts, United States
🇺🇸New York University Langone Orthopedics, New York, New York, United States
Effect of Probiotics Among Overweight and Obese Saudi Adults
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- King Saud University
- Target Recruit Count
- 90
- Registration Number
- NCT05667038
- Locations
- 🇸🇦
King Saud University, Riyadh, Saudi Arabia
Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal
Phase 2
Recruiting
- Conditions
- Environmental Enteric Dysfunction
- Interventions
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Institut Pasteur de Dakar
- Target Recruit Count
- 76
- Registration Number
- NCT05501470
- Locations
- 🇸🇳
Centre de santé de Wakhinane, Guédiawaye, Dakar, Senegal
Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Target Recruit Count
- 42
- Registration Number
- NCT05160350
- Locations
- 🇮🇷
Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of
Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer
Early Phase 1
Completed
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Stage II Lung Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Breast AdenocarcinomaStage I Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT04857697
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
Anticaries Effect of Xylitol,Probiotic and Chlorhexidine Mouth Rinses Among Individuals at High Risk
Phase 2
Completed
- Conditions
- MouthwashesCariostatic Agents
- Interventions
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Dr. Krupa NC
- Target Recruit Count
- 60
- Registration Number
- NCT04399161
- Locations
- 🇮🇳
JSS Dental College & Hospital, Mysore, Karnataka, India
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
- First Posted Date
- 2018-06-29
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- First Affiliated Hospital of Harbin Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT03574051
- Locations
- 🇨🇳
First affiliated hospital of Harbin medical university, Harbin, Heilongjiang, China
Probiotics in PBC Patients of Poor Response to UDCA
Phase 2
- Conditions
- Primary Biliary Cholangitis (PBC)
- Interventions
- Dietary Supplement: Placebo
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 60
- Registration Number
- NCT03521297
- Locations
- 🇨🇳
Third Affliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath